Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Diarrhea × Theophylline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Diarrhea 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Octreotide 3 Irinotecan 2 cabazitaxel 1 XRP6258 1 Theophylline 1 Surveys and Questionnaires 1 Sugars 1 Prednisone 1 PHY 906 1 Leucovorin 1 Lapatinib 1 Fluorouracil 1 Erlotinib Hydrochloride 1 Endoscopy 1 Drugs, Investigational 1 Capecitabine 1 Calcium Aluminosilicate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02080078 2019-05-03

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

AHS Cancer Control Alberta

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Diarrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡